Teva looks to amp up research collaborations, CEO says
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva Pharmaceuticals Lays Off Half Its Israeli Workers
TEVA News Today | Why did Teva Pharmaceutical Industries stock go down today?
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Allergan to own 10% stake in Teva
teva News and latest stories | The Jerusalem Post
Teva's flagship drug Austedo scores new approval at the FDA
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Allergan on $40.5 Billion Drug Deal - The New York Times
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva CEO Schultz likely won't renew employment contract: reports
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
New York could get $524M under opioid settlements with Teva - ABC News
Teva Pharmaceutical Rallies, So Let's Adjust Our Bullish Strategy - RealMoney
Teva x Sankuanz Team Up for Hurricane Sandal at Opening Ceremony – Footwear News
